DNA Vaccine Market Size, Growth, Analysis, Trends & Forecast to 2022 DNA Vaccine Market Size, Growth, Analysis 2017

DNA Vaccine Market Size, Growth, Analysis,
Trends & Forecast to 2022: Radiant Insights,
Inc
“The DNA vaccine market is estimated to reach US$ 7
Billion by the end of 2016.”
The DNA vaccine in this report refers to the vaccines manufactured using recombinant DNA
technology. The advent of these vaccines has revolutionized the healthcare market. These vaccines
are more effective, as well as have less side-effects associated with them as compared to
traditional vaccines. Various vaccines have been introduced in the market based on this technique.
Some of the major DNA vaccines include GlaxoSmithKline's Engerix-B, Twinrix, and Fendrix;
Merck's Gardasil, and Recombivax HB; Protein Sciences Corporation's Flublok, etc. Currently, the
researchers are engaged in developing genetic vaccines for humans. Animal genetic vaccines are
already present in the market. These vaccines are third generation vaccines, and contain DNA that
codes for specific proteins from a pathogen. This DNA is injected into host body and produces
protein for which the body generates immune response.
This comprehensive report by RNCOS entitled "Global DNA Vaccine Market Outlook 2022" provides
an in-depth analysis of the global DNA Vaccines market, presenting readers a profound
understanding of the various challenges, drivers, and developments in this industry.
View Full Report with TOC @ http://www.radiantinsights.com/research/global-dna-
vaccine-market-outlook-2022
Follow Us: